Forecast: Renin-Angiotensin System Medicine Sales in Italy

The sales forecast for Renin-Angiotensin System medicines in Italy shows a decreasing trend from 2024 to 2028. Starting at 1.09 billion USD in 2024, sales are expected to decline, reaching 0.7372 billion USD by 2028. This forecast indicates a consistent drop, averaging a -9.07% annual decline over the period. In 2023, sales stood at an estimated 1.10 billion USD, indicating the start of this downward trend.

Future trends to watch for include:

• Shifts in healthcare policies influencing drug sales.
• Presence of new generic drugs impacting market dynamics.
• Technological advancements altering treatment methodologies.
• Economic factors, including pricing pressures and reimbursement schemes.